DSGN

DESIGN THERAPEUTICS INC

DSGN·25056L103·US·Common Stock·Healthcare - Biotechnology-Activist

DSGN (DESIGN THERAPEUTICS INC) is held by 81 institutional investors as of Q2 2026. Largest holders: BAKER BROS. ADVISORS LP ($38.8M), DRIEHAUS CAPITAL MANAGEMENT LLC ($38.5M), BlackRock, Inc. ($38.5M). Net institutional sentiment: Mixed.

81
Holders
(7 Elite)
$335.2M
Total Value
64% (83)
Consensus
53 buying - 30 selling
13F: Insider & Congress: Updated regularly
DSGN

Smart Money Verdict

View all
Loading verdict
Held by 81 funds
7 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Aug 14, 2025 · Activists Aug 14, 2026 · Congress none

ActivistSISirenia Capital Management LP9.5%Aug 14, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.3.8%Aug 14, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.5.1%Jun 9, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
2.7M(+3.6%)$38.8M0.2%+5.19%
36
Increased
2.7M(+52.5%)$38.5M0.2%+12.23%
49
Increased
2.7M(+24.7%)$38.5M0.0%+37.49%
36
Decreased
2.4M(-13.1%)$34.2M0.0%+51.38%
0
Increased
1.6M(+16.4%)$22.7M0.0%+2.64%
33
Increased
1.1M(+1189.5%)$16.2M0.1%-22.75%
45
Increased
958,417(+38.4%)$13.9M0.0%-28.76%
37
Decreased
776,462(-2.8%)$11.2M0.0%—
0
Increased
765,425(+16.6%)$11.1M0.0%+19.75%
32
Increased
736,221(+11.6%)$10.7M0.0%—
31
Decreased
700,354(-27.2%)$10.1M0.0%+76.86%
0
Increased
694,743(+60.9%)$10.1M0.0%+13.22%
40
Increased
656,584(+30.1%)$9.5M0.0%—
35
Increased
565,597(+95.5%)$8.2M0.0%-9.91%
44
Increased
437,079(+1178.6%)$6.3M0.0%-22.74%
44
Decreased
387,913(-5.0%)$5.6M0.0%+100.92%
0
Increased
353,197(+17.6%)$5.1M0.0%-23.68%
31
Increased
271,264(+12.3%)$3.9M0.0%-22.76%
30
Increased
251,442(+81.5%)$3.6M0.0%-9.13%
41
Increased
230,202(+17.7%)$3.3M0.0%+2.24%
31

Showing 1-20 of 88

1 / 5
DSGNDSGNDESIGN THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used